Screening and treatment by the primary care provider of common diabetes complications

Med Clin North Am. 2015 Jan;99(1):201-19. doi: 10.1016/j.mcna.2014.09.002. Epub 2014 Oct 25.

Abstract

Diabetes is the leading cause of end-stage renal disease, blindness, and nontraumatic lower-limb amputation. The largest reductions in cardiovascular events are seen when multiple risk factors are addressed simultaneously. The benefit of aspirin as secondary prevention in patients with previous stroke or myocardial infarction has been well established. Regular, dilated eye examinations are effective in detecting sight-threatening diabetic retinopathy and have been shown to prevent blindness. The use of appropriate tools and clinical examination/inspection provides greater than 87% specificity in detecting diabetic peripheral neuropathy. Early treatment of risk factors, including hypertension, hyperglycemia, and dyslipidemia can delay or prevent diabetic nephropathy.

Keywords: Cardiovascular disease; Diabetic nephropathy; Diabetic peripheral neuropathy; Diabetic retinopathy; Macrovascular complications; Microvascular complications.

Publication types

  • Review

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Blindness / etiology
  • Blindness / prevention & control*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Complications* / classification
  • Diabetes Complications* / diagnosis
  • Diabetes Complications* / therapy
  • Dyslipidemias* / complications
  • Dyslipidemias* / diagnosis
  • Dyslipidemias* / drug therapy
  • Early Diagnosis
  • Early Medical Intervention
  • Humans
  • Hypertension* / complications
  • Hypertension* / diagnosis
  • Hypertension* / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / prevention & control*
  • Mass Screening* / methods
  • Mass Screening* / organization & administration
  • Primary Health Care / methods
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents
  • Hypoglycemic Agents